- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05706857
Evaluation of the Clinical Impact of Ultra Fast-Track in Patients Undergoing Cardiac Surgery (CARDU-FAST)
September 30, 2023 updated by: Lourdes Montero Cruces, Hospital San Carlos, Madrid
Evaluation of the Clinical Impact of Ultra Fast-Track in Patients Undergoing Cardiac Surgery Versus Conventional Extubation (CARDU-FAST)
Single center randomized clinical trial.
The main aim is to demonstrate the superiority at the clinical level of the ultra fast-track programs versus conventional early postoperative extubation in patients undergoing cardiac surgery.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
The study is aimed to compare clinical superiority of ultra fast-track versus conventional early postoperative extubation in patients undergoing cardiac surgery in our center.
The estimated sample size is 382 patients.
They will be randomized 1:1 to any of the two arms of the study (ultra fast-track vs. fast-track).
The randomization will be stratified according the type of surgery performed.
The period of recruitment will start in January 2023 and is supposed to finish by December 2024 or earlier.
The main outcomes of the study will be measured 1 year after the procedure.
Study Type
Interventional
Enrollment (Estimated)
382
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Lourdes Montero Cruces
- Phone Number: 616622432
- Email: lourdes.montero@salud.madrid.org
Study Locations
-
-
-
Madrid, Spain, 28040
- Recruiting
- Hospital Clínico San Carlos
-
Contact:
- Lourdes Montero Cruces
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Patients over 18 years of age.
- Patients with valvular, coronary or aortic heart disease with an indication for major cardiac surgery.
- The patient's desire to participate in the clinical trial verified by signing the informed consent.
Exclusion Criteria:
- Pregnancy.
- Emergent surgery or cardiorespiratory arrest.
- Patient in preoperative cardiogenic shock, or in need of high-dose vasoactive support.
- Aortic arch procedures.
- Procedures in which hypothermia < 28ºC of temperature is expected during the intervention.
- Minor cardiac surgery procedures.
- Procedures with minimally invasive techniques without extracorporeal circulation (Transcatheter aortic valve implantation, Transcatheter mitral valve implantation, Minimally invasive mitral valve repair (TOP-Mini), Totally thoracoscopic MAZE procedure, Minimally invasive direct coronary artery bypass grafting).
- Implantation of circulatory assistance devices or ECMO (extracorporeal membrane oxygenation).
- Active endocarditis.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Ultra fast-track
Patients are extubated in the operating room after the procedure
|
Patients are extubated in the operating room
|
Active Comparator: Conventional extubation
Patients are extubated in the intensive unit care
|
Patients are extubated in the operating room
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Determine the effect of Ultra Fast-track
Time Frame: 1 year
|
Determine the effect of Ultra Fast-track on the occurrence of the composite outcome composed of all-cause mortality, respiratory complications (prolonged intubation over 24h, reintubation, or pneumonia) and AKIN-III (acute renal failure) in patients undergoing ultra fast-track and patients with conventional postoperative extubation.
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Procedural resources conpsumption
Time Frame: 1 year
|
Comparison of operating room occupancy time (minutes), ICU stay and overall postoperative stay (days).
|
1 year
|
Differences in the need for high flow nasal oxygen therapy or non-invasive ventilation for >24h.
Time Frame: 1 year
|
Comparison of the need for high flow nasal oxygen therapy or non-invasive ventilation for >24h after the procedure.
|
1 year
|
Differences in major bleeding or life-threatening bleeding.
Time Frame: 1 year
|
Comparison of the event of major bleeding or life-threatening bleeding (VARC 2 definition).
|
1 year
|
Differences in neurological complication
Time Frame: 1 year
|
Comparison of the incidence of neurological complication after the procedure.
|
1 year
|
Differences in the incidence of acute myocardial infarction.
Time Frame: 1 year
|
Comparison of the incidence of acute myocardial infarction after the procedure.
|
1 year
|
Differences in the incidence of heart reoperation
Time Frame: 1 year
|
Comparison of the reoperation rate after the procedure.
|
1 year
|
Differences in the incidence of infections rate.
Time Frame: 1 year
|
Comparison of the incidence of infection that requires intravenous antibiotic therapy, which causes an increase in hospital stay or engage patient's life.
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Lourdes Montero Cruces, Hospital San Carlos, Madrid
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 22, 2023
Primary Completion (Estimated)
December 31, 2024
Study Completion (Estimated)
December 31, 2025
Study Registration Dates
First Submitted
January 20, 2023
First Submitted That Met QC Criteria
January 30, 2023
First Posted (Actual)
January 31, 2023
Study Record Updates
Last Update Posted (Actual)
October 3, 2023
Last Update Submitted That Met QC Criteria
September 30, 2023
Last Verified
September 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 22/720-EC_X
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Surgery
-
3MRecruitingAbdominal Surgery | Orthopedic Surgery | Vascular Surgery | Cardiovascular SurgeryUnited States
-
Vanderbilt UniversityCompletedHand Surgery | Wrist Surgery | Forearm Surgery | Elbow SurgeryUnited States
-
Nantes University HospitalCompletedGynecological Surgery | Plastic Surgery | ENT SurgeryFrance
-
Edwards LifesciencesCompletedAbdominal Surgery | Pelvic Surgery | Non-Cardiac/ Non-Thoracic Surgery | Major Peripheral Vascular SurgeryUnited States
-
Maquet Cardiopulmonary GmbHNAMSARecruitingCardiac Surgery | Cardiopulmonary Bypass | Thoracic Surgery | Vascular SurgerySpain
-
Baylor Research InstituteChiesi USA, Inc.RecruitingSurgery | Cardiac Surgery | Surgery--Complications | Percutaneous Coronary InterventionUnited States
-
Vanderbilt UniversityEdwards LifesciencesCompletedCardiac Surgery | Thoracic Surgery | Heart Surgery | Heart Transplant
-
Cairo UniversityBatterjee Medical College; Taif UniversityCompletedSurgery | Bariatric SurgeryEgypt, Saudi Arabia
-
Surgify Medical OyCompletedSurgery | Spine SurgeryFinland
-
Poudre Valley Health SystemTerminatedSurgery | Surgery--ComplicationsUnited States
Clinical Trials on Ultra Fast-track
-
Brigham and Women's HospitalDuke University; Weill Medical College of Cornell University; Florida International... and other collaboratorsCompleted
-
University of CalgaryThe Lung AssociationUnknownSleep Disordered BreathingCanada
-
University Hospital, GenevaCompletedMyocardial InfarctionSwitzerland
-
University of AarhusCentral Denmark Region; Aalborg University Hospital; TRYG FoundationCompletedSurgical TrainingDenmark
-
Seoul National University HospitalCompletedColorectal TumorKorea, Republic of
-
Cairo UniversityCompleted
-
Mansoura UniversityEnrolling by invitation
-
Herning HospitalCompleted
-
National and Kapodistrian University of AthensSaint Savvas Anticancer HospitalCompletedCancer of Pancreas | Hepatic Cancer